Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Patricia Vrignaud, Dorothée Semiond, Veronique Benning, Eric Beys, Hervé Bouchard & Sunil Gupta. (2014) Preclinical profile of cabazitaxel. Drug Design, Development and Therapy 8, pages 1851-1867.
Read now
Read now
Fernanda Milanezi, Silvia Carvalho & Fernando C Schmitt. (2008) EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy. Expert Review of Molecular Diagnostics 8:4, pages 417-434.
Read now
Read now
Richard M. Gallo & David J. Riese II. (2007) The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056. Growth Factors 25:5, pages 329-333.
Read now
Read now
Articles from other publishers (30)
Noura Al‐Zeheimi & Sirin A. Adham. (2020) Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP‐1 and HER2 expression and converted MCF7 breast cancer subtype. British Journal of Pharmacology 177:9, pages 2024-2041.
Crossref
Crossref
Sungbin Park, Heejoo Kim, Hwee Won Ji, Hyeon Woo Kim, Sung Hwan Yun, Eun Ha Choi & Sun Jung Kim. (2019) Cold Atmospheric Plasma Restores Paclitaxel Sensitivity to Paclitaxel-Resistant Breast Cancer Cells by Reversing Expression of Resistance-Related Genes. Cancers 11:12, pages 2011.
Crossref
Crossref
Jizhuang Wang, Chuanzhen Hu, Jun Wang, Yuhui Shen, Qiyuan Bao, Fangzhou He, Hongyi Wang, Liangzhi Gong, Zhuochao Liu, Fangqiong Hu, Jing Liang, Qi Zhou, Li Wei, Junxiang Wen & Weibin Zhang. (2019) Checkpoint Blockade in Combination With Doxorubicin Augments Tumor Cell Apoptosis in Osteosarcoma. Journal of Immunotherapy 42:9, pages 321-330.
Crossref
Crossref
Siao-Syun Guan, Cheng-Tien Wu, Chen-Yuan Chiu, Tsai-Yueh Luo, Jeng-Yih Wu, Tse-Zung Liao & Shing-Hwa Liu. (2018) Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo. Journal of Translational Medicine 16:1.
Crossref
Crossref
YONGPING LIU, YANG LING, QIUFENG QI, MING ZHU, MEIZHEN WAN, YAPING ZHANG & CHANGSONG ZHANG. (2015) Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins. Oncology Letters 9:2, pages 999-1005.
Crossref
Crossref
Yalai Bai, Huan Cheng, Jennifer Bordeaux, Veronique Neumeister, Sudha Kumar, David L. Rimm & David F. Stern. (2013) Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment Method. PLoS ONE 8:11, pages e79901.
Crossref
Crossref
Patricia Vrignaud, Dorothée Sémiond, Pascale Lejeune, Hervé Bouchard, Loreley Calvet, Cecile Combeau, Jean-François Riou, Alain Commerçon, François Lavelle & Marie-Christine Bissery. (2013) Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors. Clinical Cancer Research 19:11, pages 2973-2983.
Crossref
Crossref
Laura Cortesi, Elisabetta De Matteis, Claudia Cirilli, Luigi Marcheselli, Manuela Proietto & Massimo Federico. (2018) Outcome Evaluation in Pre-Trastuzumab Era between Different Breast Cancer Phenotypes: A Population-Based Study on Italian Women. Tumori Journal 98:6, pages 743-750.
Crossref
Crossref
S. Murray, E. Briasoulis, H. Linardou, D. Bafaloukos & C. Papadimitriou. (2012) Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies. Cancer Treatment Reviews 38:7, pages 890-903.
Crossref
Crossref
Joep P.J. de Hoon, Jürgen Veeck, Birgit E.P.J. Vriens, Tim G.A. Calon, Manon van Engeland & Vivianne C.G. Tjan-Heijnen. (2012) Taxane resistance in breast cancer: A closed HER2 circuit?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1825:2, pages 197-206.
Crossref
Crossref
Yalai Bai, Juliana Tolles, Huan Cheng, Summar Siddiqui, Arun Gopinath, Eirini Pectasides, Robert L Camp, David L Rimm & Annette M Molinaro. (2011) Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables. Laboratory Investigation 91:8, pages 1253-1261.
Crossref
Crossref
Naoki Hayashi, Takayuki IwamotoAna M. Gonzalez‐AnguloJaime Ferrer‐Lozano, Ana Lluch, Naoki Niikura, Chandra Bartholomeusz, Seigo NakamuraGabriel N. Hortobagyi & Naoto T. Ueno. (2011)
Prognostic Impact of Phosphorylated HER‐2 in HER‐2
+
Primary Breast Cancer
. The Oncologist 16:7, pages 956-965.
Crossref
Crossref
Inchoel Shin, Hyun Joo Kim, Won Heum Nah, Hyun Jun Park, Myung Chan Gye & Hae Young Park. (2011) Expression of activated HER2 in human testes. Fertility and Sterility 95:8, pages 2725-2728.
Crossref
Crossref
Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman & John Winslow. (2011) Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action. Breast Cancer Research 13:2.
Crossref
Crossref
Bhavatarini Vangamudi, Dun-Fa Peng, Qiuyin Cai, Wael El-Rifai, Wei Zheng & Abbes Belkhiri. (2010) t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer. Molecular Cancer 9:1.
Crossref
Crossref
Sharon A Glynn, Robyn L Prueitt, Lisa A Ridnour, Brenda J Boersma, Tiffany M Dorsey, David A Wink, Julie E Goodman, Harris G Yfantis, Dong H Lee & Stefan Ambs. (2010) COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer 10:1.
Crossref
Crossref
Isabel F Pinhel, Fiona A MacNeill, Margaret J Hills, Janine Salter, Simone Detre, Roger A'Hern, Ashutosh Nerurkar, Peter Osin, Ian E Smith & Mitch Dowsett. (2010) Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Research 12:5.
Crossref
Crossref
Pei Yu, Ling Zhou, Weifeng Ke & Ke Li. (2010) Clinical significance of pAKT and CD44v6 overexpression with breast cancer. Journal of Cancer Research and Clinical Oncology 136:8, pages 1283-1292.
Crossref
Crossref
Jeffrey S. Ross, Elzbieta A. Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin & Gabriel N. Hortobagyi. (2009) The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine. The Oncologist 14:4, pages 320-368.
Crossref
Crossref
Franklin L. Chen, Wenle Xia & Neil L. Spector. (2008) Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors. Clinical Cancer Research 14:21, pages 6730-6734.
Crossref
Crossref
Kiyomi Taniyama, Katsunari Ishida, Tamaki Toda, Junichi Motoshita, Kazuya Kuraoka, Akihisa Saito, Yoichi Tani, Toshinori Uike, Seiichi Teramoto & Masato Koseki. (2008) Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas. Breast Cancer 15:3, pages 231-240.
Crossref
Crossref
Barbara T. McGrogan, Breege Gilmartin, Desmond N. Carney & Amanda McCann. (2008) Taxanes, microtubules and chemoresistant breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:2, pages 96-132.
Crossref
Crossref
Shou-Ching Tang. (2008) Predictive Markers of Tubulin-Targeting Agents in Breast Cancer. Clinical Breast Cancer 8, pages S79-S84.
Crossref
Crossref
Yanyuan Wu, Hezla Mohamed, Ram Chillar, Ishrat Ali, Sheila Clayton, Dennis Slamon & Jaydutt V Vadgama. (2008) Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer. Breast Cancer Research 10:1.
Crossref
Crossref
E. Azambuja, V. Durbecq, D.D. Rosa, M. Colozza, D. Larsimont, M. Piccart-Gebhart & F. Cardoso. (2008) HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer. Annals of Oncology 19:2, pages 223-232.
Crossref
Crossref
T.A. Grushko, V.L. Filiaci, A.J. Mundt, K. Ridderstr?le, O.I. Olopade & G.F. Fleming. (2008) An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group study. Gynecologic Oncology 108:1, pages 3-9.
Crossref
Crossref
Vassiliki Karantza-Wadsworth, Shyam Patel, Olga Kravchuk, Guanghua Chen, Robin Mathew, Shengkan Jin & Eileen White. (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes & Development 21:13, pages 1621-1635.
Crossref
Crossref
Anil Potti, Holly K Dressman, Andrea Bild, Richard F Riedel, Gina Chan, Robyn Sayer, Janiel Cragun, Hope Cottrill, Michael J Kelley, Rebecca Petersen, David Harpole, Jeffrey Marks, Andrew Berchuck, Geoffrey S Ginsburg, Phillip Febbo, Johnathan Lancaster & Joseph R Nevins. (2006) Genomic signatures to guide the use of chemotherapeutics. Nature Medicine 12:11, pages 1294-1300.
Crossref
Crossref
Sabeeha Muneer, Susan Peck & Joyce A. O'Shaughnessy. (2006) Highlights from: the 42nd Annual Meeting of the American Society of Clinical Oncology; Atlanta, GA, June 2006. Clinical Breast Cancer 7:4, pages 306-314.
Crossref
Crossref
Carol Lovegrove. (2006) Activated HER2 expression and resistance to taxane chemotherapy. Nature Clinical Practice Oncology 3:1, pages 9-10.
Crossref
Crossref